Rasburicase is a recombinant urate-oxidase enzyme produced by a genetically modified Saccharomyces cerevisiae strain. The cDNA coding for rasburicase was cloned from a strain of Aspergillus flavus.
For treatment of hyperuricemia, reduces elevated plasma uric acid levels (from chemotherapy)
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.